journal article·2024-02-28

Teaching an Old Dog New Tricks: A Global Approach to Enhancing the Cytotoxicity of Drug-Loaded, Non-responsive Micelles Using Oligoelectrolytes

Md. Saddam Hussain, Riya Khetan, Andrew J. Clulow, Raja Ganesan, Alexander MacMillan, Nirmal Robinson, Aria Ahmed-Cox, Marta Krasowska, Hugo Albrecht, Anton Blencowe

Publisher page

Abstract

Polymeric micelles have been extensively studied as vectors for the delivery of hydrophobic drugs for the treatment of cancers and other diseases. Despite intensive research, few formulations provide significant benefits, and even fewer have been clinically approved. While many traditional non-responsive micelles have excellent safety profiles, they lack the ability to respond to the intracellular environment and release their cargo in a spatiotemporally defined manner to effectively deliver large doses of cytotoxic drugs into the cytosol of cells that overwhelm efflux pumps. As a novel and adaptable strategy, we hypothesized that well-established non-responsive polymeric micelles could be augmented with a pH-trigger via the co-encapsulation of cytocompatible oligoelectrolytes, which would allow rapid cargo release in the endosome, leading to increased cytotoxicity. Herein, we demonstrate how this strategy can be applied to render non-responsive micelles pH-responsive, resulting in abrupt cargo release at specific and tunable pH values compatible with endosomal delivery, which significantly increased their cytotoxicity up to 3-fold in an ovarian adenocarcinoma (SKOV-3) cell line compared to non-responsive micelles. In comparison, the oligoelectrolyte-loaded micelles were significantly less toxic to healthy 3T3 fibroblasts, indicating a selective cargo release in cancer cell lines. Oligoelectrolytes can be co-encapsulated in the micelles along with drugs at high encapsulation efficiency percentages, which are both ejected from the micelle core upon oligoelectrolyte ionization. Mechanistically, the increase in cytotoxicity appears to also result from the accelerated endosomal escape of the cargo caused by disruption of the endosomal membrane by the simultaneous release of the oligoelectrolytes from the micelles. Furthermore, we show how this approach is broadly applicable to non-responsive micelles regardless of their composition and various classes of hydrophobic chemotherapeutics. The preliminary studies presented here reveal the versatility and wide scope of oligoelectrolyte-mediated, pH-triggered drug release as a compelling and powerful strategy to enhance the cytotoxicity of non-responsive polymeric micelles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Applied Chemistry and Translational Biomaterials (ACTB) Group, Centre for Pharmaceutical Innovation (CPI), UniSA CHS, University of South Australia, Adelaide, South Australia 5000, Australia

Centre for Pharmaceutical Innovation (CPI), UniSA CHS, University of South Australia, Adelaide, South Australia 5000, Australia

Australian Synchrotron, Australian Nuclear Science and Technology Organisation (ANSTO), 800 Blackburn Road, Clayton, Victoria 3168, Australia

Drug Delivery, Disposition & Dynamics, Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville, Victoria 3052, Australia

Centre for Cancer Biology, UniSA CHS, University of South Australia, Adelaide, South Australia 5000, Australia

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, New South Wales 2033, Australia

Children’s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales 2750, Australia

Australian Centre for Nanomedicine, Faculty of Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia

Surface Interactions and Soft Matter (SISM) Group, Future Industries Institute, UniSA STEM, University of South Australia, Mawson Lakes, South Australia 5095, Australia

Funding

H2020 Research Infrastructures · Australian Nuclear Science and Technology Organisation

References (74)

Show source-provided references
1. 10.1016/j.nantod.2020.10100810.1016/j.nantod.2020.101008 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.1007/s11095-010-0233-410.1007/s11095-010-0233-4 ↗
4. 10.3390/pharmaceutics1408163610.3390/pharmaceutics14081636 ↗
5. 10.1016/j.apsb.2022.02.02510.1016/j.apsb.2022.02.025 ↗
6. 10.1007/s40005-022-00607-610.1007/s40005-022-00607-6 ↗
7. 10.1016/j.jconrel.2021.02.03110.1016/j.jconrel.2021.02.031 ↗
8. 10.1016/j.biomaterials.2008.09.01010.1016/j.biomaterials.2008.09.010 ↗
9. 10.1002/app.4573210.1002/app.45732 ↗
10. 10.1371/journal.pone.011220010.1371/journal.pone.0112200 ↗
11. 10.1007/s10856-015-5610-410.1007/s10856-015-5610-4 ↗
12. 10.1177/088391151771565810.1177/0883911517715658 ↗
13. 10.3181/0702-RM-3110.3181/0702-RM-31 ↗
14. 10.1371/journal.pone.000605610.1371/journal.pone.0006056 ↗
15. 10.1021/acs.bioconjchem.8b0077810.1021/acs.bioconjchem.8b00778 ↗
16. 10.1021/acs.bioconjchem.8b0073210.1021/acs.bioconjchem.8b00732 ↗
17. 10.4103/2141-9248.10567110.4103/2141-9248.105671 ↗
18. 10.2147/IJN.S15869610.2147/IJN.S158696 ↗
19. 10.1002/mabi.20170002210.1002/mabi.201700022 ↗
20. 10.1016/j.jconrel.2012.07.01110.1016/j.jconrel.2012.07.011 ↗
21. 10.1021/bm900074d10.1021/bm900074d ↗
22. 10.1016/j.jconrel.2010.12.00510.1016/j.jconrel.2010.12.005 ↗
23. 10.1021/bm501290t10.1021/bm501290t ↗
24. 10.1039/c3tb21694b10.1039/c3tb21694b ↗
25. 10.1016/j.colsurfb.2017.07.06310.1016/j.colsurfb.2017.07.063 ↗
26. 10.1039/C7RA04358A10.1039/C7RA04358A ↗
27. 10.1021/acsami.7b0112010.1021/acsami.7b01120 ↗
28. 10.3390/pharmaceutics1503097710.3390/pharmaceutics15030977 ↗
29. 10.1039/b714741d10.1039/b714741d ↗
30. 10.1016/j.ijpharm.2008.03.00310.1016/j.ijpharm.2008.03.003 ↗
31. 10.1038/natrevmats.2016.7510.1038/natrevmats.2016.75 ↗
32. 10.1007/s11095-015-1830-z10.1007/s11095-015-1830-z ↗
33. 10.1021/la026339b10.1021/la026339b ↗
34. 10.1002/jps.2103710.1002/jps.21037 ↗
35. 10.1016/S0142-9612(03)00207-210.1016/S0142-9612(03)00207-2 ↗
36. 10.1016/j.ijpharm.2010.01.01510.1016/j.ijpharm.2010.01.015 ↗
37. National Institue of Health, ClinicalTrials.gov Records for Polymeric Micelle Trials in Humans (accessed 17th August 2023): https://clinicaltrials.gov/ct2/results?cond=&term=polymer+micelles&cntry=&state=&city=&dist.
38. 10.1016/j.cclet.2020.11.02910.1016/j.cclet.2020.11.029 ↗
39. 10.1016/j.ijpharm.2012.01.03410.1016/j.ijpharm.2012.01.034 ↗
40. 10.1021/la00092a03810.1021/la00092a038 ↗
41. 10.1016/j.polymer.2007.09.02110.1016/j.polymer.2007.09.021 ↗
42. 10.3390/pharmaceutics1104017610.3390/pharmaceutics11040176 ↗
43. 10.3390/pharmaceutics1202017010.3390/pharmaceutics12020170 ↗
44. 10.1016/j.ejps.2014.07.00710.1016/j.ejps.2014.07.007 ↗
45. 10.1021/acs.langmuir.2c0090510.1021/acs.langmuir.2c00905 ↗
46. 10.1016/j.jinorgbio.2003.10.00110.1016/j.jinorgbio.2003.10.001 ↗
47. 10.1021/ma981269u10.1021/ma981269u ↗
48. 10.1021/ma960629f10.1021/ma960629f ↗
49. 10.1021/acs.macromol.8b0166110.1021/acs.macromol.8b01661 ↗
50. 10.1080/19443994.2013.83700310.1080/19443994.2013.837003 ↗
51. 10.1016/j.jcis.2021.08.08410.1016/j.jcis.2021.08.084 ↗
52. 10.3390/pharmaceutics1312200710.3390/pharmaceutics13122007 ↗
53. 10.1039/D2NR00311B10.1039/D2NR00311B ↗
54. 10.1016/j.nano.2007.12.00210.1016/j.nano.2007.12.002 ↗
55. 10.3390/ijms2112439210.3390/ijms21124392 ↗
56. 10.1016/j.nano.2010.11.00410.1016/j.nano.2010.11.004 ↗
57. 10.1038/nrd259110.1038/nrd2591 ↗
58. 10.1016/j.jconrel.2014.06.03810.1016/j.jconrel.2014.06.038 ↗
59. 10.1021/acs.jmedchem.8b0126310.1021/acs.jmedchem.8b01263 ↗
60. 10.1038/srep0199710.1038/srep01997 ↗
61. 10.2147/IJN.S3611110.2147/IJN.S36111 ↗
62. 10.1007/s10924-022-02654-410.1007/s10924-022-02654-4 ↗
63. 10.1186/s11671-018-2728-610.1186/s11671-018-2728-6 ↗
64. 10.1021/acsnano.0c0066610.1021/acsnano.0c00666 ↗
65. 10.1242/jeb.200.1.110.1242/jeb.200.1.1 ↗
66. 10.1038/s41419-018-0508-y10.1038/s41419-018-0508-y ↗
67. 10.1083/jcb.116.1.9510.1083/jcb.116.1.95 ↗
68. 10.5402/2012/62313910.5402/2012/623139 ↗
69. 10.1021/cr60208a00210.1021/cr60208a002 ↗
70. 10.1152/physiol.00005.200410.1152/physiol.00005.2004 ↗
71. Tokarev A. A. · 2009 · 310.1007/978-0-387-93877-6_1 ↗
72. 10.1042/bj250000110.1042/bj2500001 ↗
73. 10.1016/j.addr.2016.08.01410.1016/j.addr.2016.08.014 ↗
74. 10.1002/jssc.20080048210.1002/jssc.200800482 ↗